by Fran Rizzi
Thirty City of Hope scientists and physicians shared ongoing innovative research on topics from kidney cancer to sarcoma at the institution’s inaugural Developmental Cancer Therapeutics Program retreat on Oct. 14.
Nearly 100 of their colleagues gathered at City of Hope to hear a blend of news about basic, translational and clinical research under way on campus. The presentations, held in Cooper Auditorium, highlighted staff members’ current investigations and outlined their plans for furthering potential treatments.
The event showcased scientists’ creative collaborations not only within City of Hope, but also with researchers nationwide.
“This was an exciting forum for our scientists and clinicians — some of the best minds in cancer research and treatment — to share their work with colleagues,” said Richard Jove, Ph.D., co-director of the Developmental Cancer Therapeutics Program and deputy director of City of Hope Cancer Center. “Many of them are here because the Cancer Center provides a collaborative environment that empowers them to take bold steps toward finding more effective cures. I’m delighted to see them energized by each other and becoming even more committed to the mission of curing cancer together.”
The growing Developmental Cancer Therapeutics Program advances knowledge on the molecular basis of cancer to urgently push for novel agents that fight cancer more effectively and with fewer side effects. Over the long term, scientists in the program aim to match individual patients with the most appropriate therapies for the best clinical outcomes.
